Sorting hidden patterns in nanoparticle performance for glioblastoma using machine learning algorithms.

Area of Science:

• Nanomedicine
• Materials Science
• Biochemistry

Background:

• Cationic compounds enhance nanoparticle cell membrane penetration and tumor targeting but often exhibit high cytotoxicity.
• Developing safer cationic agents is crucial for effective nanomedicine applications.
• Glioblastoma targeting requires nanoparticles with specific surface properties for efficient delivery.

Purpose of the Study:

• To evaluate novel glycerol-based lipids (GLY1, GLY2) as safer cationic alternatives for nanostructured lipid carriers (NLCs).
• To investigate the impact of lipid structure on NLC properties, including zeta potential, particle size, and cytotoxicity.
• To assess the efficacy of GLY1-based NLCs for glioblastoma targeting and hemocompatibility.

Main Methods:

• Synthesis and characterization of two novel glycerol-based lipids, GLY1 and GLY2.
• Formulation of nanostructured lipid carriers (NLCs) using GLY1 and GLY2.
• Zeta potential, particle size, and cytotoxicity assays.
• Hemocompatibility studies and in vitro tumor cell uptake experiments.
• Application of machine learning (ML) for analyzing structure-property relationships.

Main Results:

• GLY1 and GLY2 effectively reversed NLCs' zeta potential to positive values.
• Machine learning revealed GLY1's superior ability to increase zeta potential and cytotoxicity while reducing particle size.
• NLCs formulated with GLY1 exhibited improved hemocompatibility and enhanced glioblastoma cell uptake.
• GLY1 demonstrated reduced cytotoxicity compared to the conventional cationic surfactant CTAB.

Conclusions:

• GLY1 represents a promising, safer cationic agent for designing effective glioblastoma-targeted NLCs.
• The study highlights the potential of glycerol-based lipids in nanomedicine formulation.
• Machine learning is a valuable tool for optimizing nanoparticle design and predicting performance.